

(Sharecast News) - Avacta Group reported a reduced pre-tax loss of £28.98m from continuing operations in 2024 on Friday, down from £31.13m t...


(Sharecast News) - Life sciences company Avacta Therapeutics has announced that it has had to delay the release of its annual results by a week.


(Alliance News) - Avacta Group PLC on Friday said it has agreed to sell its UK-based and largest diagnostics unit, Launch Diagnostics Holdings Ltd, an...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.


(Sharecast News) - Life sciences firm Avacta revealed on Friday that it has agreed to sell its UK-based diagnostics unit to Duomed Belgium for £1...


(Sharecast News) - Avacta Therapeutics announced promising results from its ongoing phase 1a trial of AVA6000 on Thursday, demonstrating meaningful tu...


(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and last week and not separate...